Stock LSB LAKESHORE BIOPHARMA CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company LakeShore Biopharma Co., Ltd

Equities

LSB

KYG9845F1090

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.835 USD -7.22% Intraday chart for LakeShore Biopharma Co., Ltd -18.14% +63.41%
May. 28 YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS CI
May. 24 YS Biopharma to Become LakeShore Biopharma, Ticker Symbol to Change to LSB From YS Starting May 28 MT

Business Summary

LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.

Number of employees: 773

Sales per Business

USD in Million2020Weight2021Weight Delta
Biopharmaceutical Products
100.0 %
38 100.0 % 78 100.0 % +106.75%

Sales per region

USD in Million2020Weight2021Weight Delta
China
100.0 %
38 100.0 % 78 100.0 % +106.75%

Managers

Managers TitleAgeSince
Hui Shao CEO
 Chief Executive Officer 55 20-12-30
Chun Yuan Wu DFI
 Director of Finance/CFO 46 20-12-30
Zenaida Mojares CTO
 Chief Tech/Sci/R&D Officer 65 21-12-31
Gang Li SAM
 Sales & Marketing 42 -

Members of the board

Members of the board TitleAgeSince
Viren Mehta BRD
 Director/Board Member 74 -
Hui Shao CEO
 Chief Executive Officer 55 20-12-30
Ajit Shetty CHM
 Chairman 77 20-12-31
Rachel Yu BRD
 Director/Board Member 50 Jan. 06
Chun Yuan Wu DFI
 Director of Finance/CFO 46 20-12-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 188,327,959 34,976,425 ( 18.57 %) 0 18.57 %

Shareholders

NameEquities%Valuation
Fung Ching Wong
52.23 %
98,360,094 52.23 % 78 M $
Yi Zhang
26.07 %
49,089,185 26.07 % 39 M $
Oceanpine Capital
2.180 %
4,105,596 2.180 % 3 M $
Bo Tan
2.046 %
3,853,475 2.046 % 3 M $
Adjuvant Capital LP
1.541 %
2,902,969 1.541 % 2 M $
Asia Partners Fund Management Pte Ltd.
1.443 %
2,718,499 1.443 % 2 M $
3W Fund Management Ltd.
1.190 %
2,240,746 1.190 % 2 M $
Hui Shao
1.088 %
2,048,780 1.088 % 2 M $
OrbiMed Advisors Private Equity
0.8148 %
1,534,430 0.8148 % 1 M $
FIL Ltd. (Subfiler)
0.6397 %
1,204,763 0.6397 % 957 787 $
NameEquities%Valuation
LMR Partners LLP
-
1,052,461 - 84 197 $
Valliance Asset Management Ltd.
-
750,000 - 60 000 $
BFAM Partners (Cayman) Ltd.
-
550,000 - 44 000 $
Jane Street Group LLC
-
498,301 - 39 864 $
Finepoint Capital LP
-
489,999 - 39 200 $
Highbridge Capital Management LLC
-
439,350 - 35 148 $
Cowen & Co. LLC
-
235,533 - 18 843 $
Bracebridge Capital LLC
-
232,323 - 18 586 $
Calamos Advisors LLC
-
146,040 - 11 683 $
Q Global Advisors LLC
-
130,600 - 10 448 $

Company contact information

YS Biopharma Co. Ltd.

Daxing Biomedical Industry Park 38 Yongda Road

102629, Beijing

+

http://www.ysbiopharm.com
address LakeShore Biopharma Co., Ltd(LSB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.047 CNY
Average target price
29.98 CNY
Spread / Average Target
+395.80%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
LAKESHORE BIOPHARMA CO., LTD Stock LakeShore Biopharma Co., Ltd
+63.41% 157M
CSL LIMITED Stock CSL Limited
-2.29% 89.87B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-3.95% 37.57B
BIOGEN INC. Stock Biogen Inc.
-13.07% 32.75B
UCB Stock UCB
+63.05% 26.47B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-22.14% 14.25B
INCYTE CORPORATION Stock Incyte Corporation
-7.96% 12.99B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.33% 11.93B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-46.33% 10.84B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.77% 9.11B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. LSB Stock
  4. Company LakeShore Biopharma Co., Ltd